Pharma & Healthcare
Global Modafinil Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 21, 25
- ID: 557431
- Pages: 148
- Figures: 143
- Views: 12
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Modafinil Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Cephalon
Aurobindo Pharma
Apotex
Sun Pharmaceutical
Watson Labs
Orbion Pharmaceuticals
Zydus
Alembic Pharma
Segment by Type
100mg per Tablet
200mg per Tablet
Segment by Application
Narcolepsy
Obstructive Sleep Apnea
Shift Work Sleep Disorder
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Modafinil Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Modafinil Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Cephalon
Aurobindo Pharma
Apotex
Sun Pharmaceutical
Watson Labs
Orbion Pharmaceuticals
Zydus
Alembic Pharma
Segment by Type
100mg per Tablet
200mg per Tablet
Segment by Application
Narcolepsy
Obstructive Sleep Apnea
Shift Work Sleep Disorder
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Modafinil Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Modafinil Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Modafinil Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 100mg per Tablet
1.2.3 200mg per Tablet
1.3 Market Segmentation by Application
1.3.1 Global Modafinil Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Narcolepsy
1.3.3 Obstructive Sleep Apnea
1.3.4 Shift Work Sleep Disorder
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Modafinil Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Modafinil Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Modafinil Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Modafinil Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Modafinil Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Modafinil Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 100mg per Tablet Market Size by Manufacturers
3.5.2 200mg per Tablet Market Size by Manufacturers
3.6 Global Modafinil Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Modafinil Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Modafinil Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Modafinil Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Modafinil Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Modafinil Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Modafinil Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Modafinil Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Modafinil Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Modafinil Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Modafinil Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Modafinil Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Modafinil Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Modafinil Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Modafinil Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Modafinil Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Modafinil Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Modafinil Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Modafinil Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Modafinil Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Cephalon
11.1.1 Cephalon Corporation Information
11.1.2 Cephalon Business Overview
11.1.3 Cephalon Modafinil Tablets Product Models, Descriptions and Specifications
11.1.4 Cephalon Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Cephalon Modafinil Tablets Sales by Product in 2024
11.1.6 Cephalon Modafinil Tablets Sales by Application in 2024
11.1.7 Cephalon Modafinil Tablets Sales by Geographic Area in 2024
11.1.8 Cephalon Modafinil Tablets SWOT Analysis
11.1.9 Cephalon Recent Developments
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Corporation Information
11.2.2 Aurobindo Pharma Business Overview
11.2.3 Aurobindo Pharma Modafinil Tablets Product Models, Descriptions and Specifications
11.2.4 Aurobindo Pharma Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Aurobindo Pharma Modafinil Tablets Sales by Product in 2024
11.2.6 Aurobindo Pharma Modafinil Tablets Sales by Application in 2024
11.2.7 Aurobindo Pharma Modafinil Tablets Sales by Geographic Area in 2024
11.2.8 Aurobindo Pharma Modafinil Tablets SWOT Analysis
11.2.9 Aurobindo Pharma Recent Developments
11.3 Apotex
11.3.1 Apotex Corporation Information
11.3.2 Apotex Business Overview
11.3.3 Apotex Modafinil Tablets Product Models, Descriptions and Specifications
11.3.4 Apotex Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Apotex Modafinil Tablets Sales by Product in 2024
11.3.6 Apotex Modafinil Tablets Sales by Application in 2024
11.3.7 Apotex Modafinil Tablets Sales by Geographic Area in 2024
11.3.8 Apotex Modafinil Tablets SWOT Analysis
11.3.9 Apotex Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Modafinil Tablets Product Models, Descriptions and Specifications
11.4.4 Sun Pharmaceutical Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sun Pharmaceutical Modafinil Tablets Sales by Product in 2024
11.4.6 Sun Pharmaceutical Modafinil Tablets Sales by Application in 2024
11.4.7 Sun Pharmaceutical Modafinil Tablets Sales by Geographic Area in 2024
11.4.8 Sun Pharmaceutical Modafinil Tablets SWOT Analysis
11.4.9 Sun Pharmaceutical Recent Developments
11.5 Watson Labs
11.5.1 Watson Labs Corporation Information
11.5.2 Watson Labs Business Overview
11.5.3 Watson Labs Modafinil Tablets Product Models, Descriptions and Specifications
11.5.4 Watson Labs Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Watson Labs Modafinil Tablets Sales by Product in 2024
11.5.6 Watson Labs Modafinil Tablets Sales by Application in 2024
11.5.7 Watson Labs Modafinil Tablets Sales by Geographic Area in 2024
11.5.8 Watson Labs Modafinil Tablets SWOT Analysis
11.5.9 Watson Labs Recent Developments
11.6 Orbion Pharmaceuticals
11.6.1 Orbion Pharmaceuticals Corporation Information
11.6.2 Orbion Pharmaceuticals Business Overview
11.6.3 Orbion Pharmaceuticals Modafinil Tablets Product Models, Descriptions and Specifications
11.6.4 Orbion Pharmaceuticals Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Orbion Pharmaceuticals Recent Developments
11.7 Zydus
11.7.1 Zydus Corporation Information
11.7.2 Zydus Business Overview
11.7.3 Zydus Modafinil Tablets Product Models, Descriptions and Specifications
11.7.4 Zydus Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zydus Recent Developments
11.8 Alembic Pharma
11.8.1 Alembic Pharma Corporation Information
11.8.2 Alembic Pharma Business Overview
11.8.3 Alembic Pharma Modafinil Tablets Product Models, Descriptions and Specifications
11.8.4 Alembic Pharma Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Alembic Pharma Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Modafinil Tablets Industry Chain
12.2 Modafinil Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Modafinil Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Modafinil Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Modafinil Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Modafinil Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Modafinil Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Modafinil Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 100mg per Tablet
1.2.3 200mg per Tablet
1.3 Market Segmentation by Application
1.3.1 Global Modafinil Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Narcolepsy
1.3.3 Obstructive Sleep Apnea
1.3.4 Shift Work Sleep Disorder
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Modafinil Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Modafinil Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Modafinil Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Modafinil Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Modafinil Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Modafinil Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 100mg per Tablet Market Size by Manufacturers
3.5.2 200mg per Tablet Market Size by Manufacturers
3.6 Global Modafinil Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Modafinil Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Modafinil Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Modafinil Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Modafinil Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Modafinil Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Modafinil Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Modafinil Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Modafinil Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Modafinil Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Modafinil Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Modafinil Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Modafinil Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Modafinil Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Modafinil Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Modafinil Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Modafinil Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Modafinil Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Modafinil Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Modafinil Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Cephalon
11.1.1 Cephalon Corporation Information
11.1.2 Cephalon Business Overview
11.1.3 Cephalon Modafinil Tablets Product Models, Descriptions and Specifications
11.1.4 Cephalon Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Cephalon Modafinil Tablets Sales by Product in 2024
11.1.6 Cephalon Modafinil Tablets Sales by Application in 2024
11.1.7 Cephalon Modafinil Tablets Sales by Geographic Area in 2024
11.1.8 Cephalon Modafinil Tablets SWOT Analysis
11.1.9 Cephalon Recent Developments
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Corporation Information
11.2.2 Aurobindo Pharma Business Overview
11.2.3 Aurobindo Pharma Modafinil Tablets Product Models, Descriptions and Specifications
11.2.4 Aurobindo Pharma Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Aurobindo Pharma Modafinil Tablets Sales by Product in 2024
11.2.6 Aurobindo Pharma Modafinil Tablets Sales by Application in 2024
11.2.7 Aurobindo Pharma Modafinil Tablets Sales by Geographic Area in 2024
11.2.8 Aurobindo Pharma Modafinil Tablets SWOT Analysis
11.2.9 Aurobindo Pharma Recent Developments
11.3 Apotex
11.3.1 Apotex Corporation Information
11.3.2 Apotex Business Overview
11.3.3 Apotex Modafinil Tablets Product Models, Descriptions and Specifications
11.3.4 Apotex Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Apotex Modafinil Tablets Sales by Product in 2024
11.3.6 Apotex Modafinil Tablets Sales by Application in 2024
11.3.7 Apotex Modafinil Tablets Sales by Geographic Area in 2024
11.3.8 Apotex Modafinil Tablets SWOT Analysis
11.3.9 Apotex Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Modafinil Tablets Product Models, Descriptions and Specifications
11.4.4 Sun Pharmaceutical Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sun Pharmaceutical Modafinil Tablets Sales by Product in 2024
11.4.6 Sun Pharmaceutical Modafinil Tablets Sales by Application in 2024
11.4.7 Sun Pharmaceutical Modafinil Tablets Sales by Geographic Area in 2024
11.4.8 Sun Pharmaceutical Modafinil Tablets SWOT Analysis
11.4.9 Sun Pharmaceutical Recent Developments
11.5 Watson Labs
11.5.1 Watson Labs Corporation Information
11.5.2 Watson Labs Business Overview
11.5.3 Watson Labs Modafinil Tablets Product Models, Descriptions and Specifications
11.5.4 Watson Labs Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Watson Labs Modafinil Tablets Sales by Product in 2024
11.5.6 Watson Labs Modafinil Tablets Sales by Application in 2024
11.5.7 Watson Labs Modafinil Tablets Sales by Geographic Area in 2024
11.5.8 Watson Labs Modafinil Tablets SWOT Analysis
11.5.9 Watson Labs Recent Developments
11.6 Orbion Pharmaceuticals
11.6.1 Orbion Pharmaceuticals Corporation Information
11.6.2 Orbion Pharmaceuticals Business Overview
11.6.3 Orbion Pharmaceuticals Modafinil Tablets Product Models, Descriptions and Specifications
11.6.4 Orbion Pharmaceuticals Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Orbion Pharmaceuticals Recent Developments
11.7 Zydus
11.7.1 Zydus Corporation Information
11.7.2 Zydus Business Overview
11.7.3 Zydus Modafinil Tablets Product Models, Descriptions and Specifications
11.7.4 Zydus Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zydus Recent Developments
11.8 Alembic Pharma
11.8.1 Alembic Pharma Corporation Information
11.8.2 Alembic Pharma Business Overview
11.8.3 Alembic Pharma Modafinil Tablets Product Models, Descriptions and Specifications
11.8.4 Alembic Pharma Modafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Alembic Pharma Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Modafinil Tablets Industry Chain
12.2 Modafinil Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Modafinil Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Modafinil Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Modafinil Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Modafinil Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Modafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Modafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Modafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Modafinil Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Modafinil Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Modafinil Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Modafinil Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Modafinil Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Modafinil Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Modafinil Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Modafinil Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Modafinil Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Modafinil Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modafinil Tablets as of 2024)
Table 16. Global Modafinil Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Modafinil Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Modafinil Tablets Manufacturing Base and Headquarters
Table 19. Global Modafinil Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Modafinil Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Modafinil Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Modafinil Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Modafinil Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Modafinil Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Modafinil Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Modafinil Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Modafinil Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Modafinil Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Modafinil Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Modafinil Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Modafinil Tablets Growth Accelerators and Market Barriers
Table 37. North America Modafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Modafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Modafinil Tablets Growth Accelerators and Market Barriers
Table 40. Europe Modafinil Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Modafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Modafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Modafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Modafinil Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Modafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Modafinil Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Modafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Modafinil Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Modafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Cephalon Corporation Information
Table 51. Cephalon Description and Major Businesses
Table 52. Cephalon Product Models, Descriptions and Specifications
Table 53. Cephalon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Cephalon Sales Value Proportion by Product in 2024
Table 55. Cephalon Sales Value Proportion by Application in 2024
Table 56. Cephalon Sales Value Proportion by Geographic Area in 2024
Table 57. Cephalon Modafinil Tablets SWOT Analysis
Table 58. Cephalon Recent Developments
Table 59. Aurobindo Pharma Corporation Information
Table 60. Aurobindo Pharma Description and Major Businesses
Table 61. Aurobindo Pharma Product Models, Descriptions and Specifications
Table 62. Aurobindo Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Aurobindo Pharma Sales Value Proportion by Product in 2024
Table 64. Aurobindo Pharma Sales Value Proportion by Application in 2024
Table 65. Aurobindo Pharma Sales Value Proportion by Geographic Area in 2024
Table 66. Aurobindo Pharma Modafinil Tablets SWOT Analysis
Table 67. Aurobindo Pharma Recent Developments
Table 68. Apotex Corporation Information
Table 69. Apotex Description and Major Businesses
Table 70. Apotex Product Models, Descriptions and Specifications
Table 71. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Apotex Sales Value Proportion by Product in 2024
Table 73. Apotex Sales Value Proportion by Application in 2024
Table 74. Apotex Sales Value Proportion by Geographic Area in 2024
Table 75. Apotex Modafinil Tablets SWOT Analysis
Table 76. Apotex Recent Developments
Table 77. Sun Pharmaceutical Corporation Information
Table 78. Sun Pharmaceutical Description and Major Businesses
Table 79. Sun Pharmaceutical Product Models, Descriptions and Specifications
Table 80. Sun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sun Pharmaceutical Sales Value Proportion by Product in 2024
Table 82. Sun Pharmaceutical Sales Value Proportion by Application in 2024
Table 83. Sun Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 84. Sun Pharmaceutical Modafinil Tablets SWOT Analysis
Table 85. Sun Pharmaceutical Recent Developments
Table 86. Watson Labs Corporation Information
Table 87. Watson Labs Description and Major Businesses
Table 88. Watson Labs Product Models, Descriptions and Specifications
Table 89. Watson Labs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Watson Labs Sales Value Proportion by Product in 2024
Table 91. Watson Labs Sales Value Proportion by Application in 2024
Table 92. Watson Labs Sales Value Proportion by Geographic Area in 2024
Table 93. Watson Labs Modafinil Tablets SWOT Analysis
Table 94. Watson Labs Recent Developments
Table 95. Orbion Pharmaceuticals Corporation Information
Table 96. Orbion Pharmaceuticals Description and Major Businesses
Table 97. Orbion Pharmaceuticals Product Models, Descriptions and Specifications
Table 98. Orbion Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Orbion Pharmaceuticals Recent Developments
Table 100. Zydus Corporation Information
Table 101. Zydus Description and Major Businesses
Table 102. Zydus Product Models, Descriptions and Specifications
Table 103. Zydus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Zydus Recent Developments
Table 105. Alembic Pharma Corporation Information
Table 106. Alembic Pharma Description and Major Businesses
Table 107. Alembic Pharma Product Models, Descriptions and Specifications
Table 108. Alembic Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Alembic Pharma Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Modafinil Tablets Product Picture
Figure 2. Global Modafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 100mg per Tablet Product Picture
Figure 4. 200mg per Tablet Product Picture
Figure 5. Global Modafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Narcolepsy
Figure 7. Obstructive Sleep Apnea
Figure 8. Shift Work Sleep Disorder
Figure 9. Other
Figure 10. Modafinil Tablets Report Years Considered
Figure 11. Global Modafinil Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 13. Global Modafinil Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Modafinil Tablets Revenue Market Share by Region (2020-2031)
Figure 15. Global Modafinil Tablets Sales (2020-2031) & (K Units)
Figure 16. Global Modafinil Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Modafinil Tablets Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Modafinil Tablets Sales Volume Market Share in 2024
Figure 19. Global Modafinil Tablets Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. 100mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 22. 200mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 23. Global Modafinil Tablets Sales Market Share by Type (2020-2031)
Figure 24. Global Modafinil Tablets Revenue Market Share by Type (2020-2031)
Figure 25. Global Modafinil Tablets Sales Market Share by Application (2020-2031)
Figure 26. Global Modafinil Tablets Revenue Market Share by Application (2020-2031)
Figure 27. North America Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 28. North America Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 30. North America Modafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Modafinil Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 40. Europe Modafinil Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Modafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 45. France Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Modafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Modafinil Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. India Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Modafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Modafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Modafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Modafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 81. Modafinil Tablets Industry Chain Mapping
Figure 82. Regional Modafinil Tablets Manufacturing Base Distribution (%)
Figure 83. Global Modafinil Tablets Production Market Share by Region (2020-2031)
Figure 84. Modafinil Tablets Production Process
Figure 85. Regional Modafinil Tablets Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Table 1. Global Modafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Modafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Modafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Modafinil Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Modafinil Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Modafinil Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Modafinil Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Modafinil Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Modafinil Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Modafinil Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Modafinil Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Modafinil Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Modafinil Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modafinil Tablets as of 2024)
Table 16. Global Modafinil Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Modafinil Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Modafinil Tablets Manufacturing Base and Headquarters
Table 19. Global Modafinil Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Modafinil Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Modafinil Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Modafinil Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Modafinil Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Modafinil Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Modafinil Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Modafinil Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Modafinil Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Modafinil Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Modafinil Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Modafinil Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Modafinil Tablets Growth Accelerators and Market Barriers
Table 37. North America Modafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Modafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Modafinil Tablets Growth Accelerators and Market Barriers
Table 40. Europe Modafinil Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Modafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Modafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Modafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Modafinil Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Modafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Modafinil Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Modafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Modafinil Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Modafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Cephalon Corporation Information
Table 51. Cephalon Description and Major Businesses
Table 52. Cephalon Product Models, Descriptions and Specifications
Table 53. Cephalon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Cephalon Sales Value Proportion by Product in 2024
Table 55. Cephalon Sales Value Proportion by Application in 2024
Table 56. Cephalon Sales Value Proportion by Geographic Area in 2024
Table 57. Cephalon Modafinil Tablets SWOT Analysis
Table 58. Cephalon Recent Developments
Table 59. Aurobindo Pharma Corporation Information
Table 60. Aurobindo Pharma Description and Major Businesses
Table 61. Aurobindo Pharma Product Models, Descriptions and Specifications
Table 62. Aurobindo Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Aurobindo Pharma Sales Value Proportion by Product in 2024
Table 64. Aurobindo Pharma Sales Value Proportion by Application in 2024
Table 65. Aurobindo Pharma Sales Value Proportion by Geographic Area in 2024
Table 66. Aurobindo Pharma Modafinil Tablets SWOT Analysis
Table 67. Aurobindo Pharma Recent Developments
Table 68. Apotex Corporation Information
Table 69. Apotex Description and Major Businesses
Table 70. Apotex Product Models, Descriptions and Specifications
Table 71. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Apotex Sales Value Proportion by Product in 2024
Table 73. Apotex Sales Value Proportion by Application in 2024
Table 74. Apotex Sales Value Proportion by Geographic Area in 2024
Table 75. Apotex Modafinil Tablets SWOT Analysis
Table 76. Apotex Recent Developments
Table 77. Sun Pharmaceutical Corporation Information
Table 78. Sun Pharmaceutical Description and Major Businesses
Table 79. Sun Pharmaceutical Product Models, Descriptions and Specifications
Table 80. Sun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sun Pharmaceutical Sales Value Proportion by Product in 2024
Table 82. Sun Pharmaceutical Sales Value Proportion by Application in 2024
Table 83. Sun Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 84. Sun Pharmaceutical Modafinil Tablets SWOT Analysis
Table 85. Sun Pharmaceutical Recent Developments
Table 86. Watson Labs Corporation Information
Table 87. Watson Labs Description and Major Businesses
Table 88. Watson Labs Product Models, Descriptions and Specifications
Table 89. Watson Labs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Watson Labs Sales Value Proportion by Product in 2024
Table 91. Watson Labs Sales Value Proportion by Application in 2024
Table 92. Watson Labs Sales Value Proportion by Geographic Area in 2024
Table 93. Watson Labs Modafinil Tablets SWOT Analysis
Table 94. Watson Labs Recent Developments
Table 95. Orbion Pharmaceuticals Corporation Information
Table 96. Orbion Pharmaceuticals Description and Major Businesses
Table 97. Orbion Pharmaceuticals Product Models, Descriptions and Specifications
Table 98. Orbion Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Orbion Pharmaceuticals Recent Developments
Table 100. Zydus Corporation Information
Table 101. Zydus Description and Major Businesses
Table 102. Zydus Product Models, Descriptions and Specifications
Table 103. Zydus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Zydus Recent Developments
Table 105. Alembic Pharma Corporation Information
Table 106. Alembic Pharma Description and Major Businesses
Table 107. Alembic Pharma Product Models, Descriptions and Specifications
Table 108. Alembic Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Alembic Pharma Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Modafinil Tablets Product Picture
Figure 2. Global Modafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 100mg per Tablet Product Picture
Figure 4. 200mg per Tablet Product Picture
Figure 5. Global Modafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Narcolepsy
Figure 7. Obstructive Sleep Apnea
Figure 8. Shift Work Sleep Disorder
Figure 9. Other
Figure 10. Modafinil Tablets Report Years Considered
Figure 11. Global Modafinil Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 13. Global Modafinil Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Modafinil Tablets Revenue Market Share by Region (2020-2031)
Figure 15. Global Modafinil Tablets Sales (2020-2031) & (K Units)
Figure 16. Global Modafinil Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Modafinil Tablets Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Modafinil Tablets Sales Volume Market Share in 2024
Figure 19. Global Modafinil Tablets Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. 100mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 22. 200mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 23. Global Modafinil Tablets Sales Market Share by Type (2020-2031)
Figure 24. Global Modafinil Tablets Revenue Market Share by Type (2020-2031)
Figure 25. Global Modafinil Tablets Sales Market Share by Application (2020-2031)
Figure 26. Global Modafinil Tablets Revenue Market Share by Application (2020-2031)
Figure 27. North America Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 28. North America Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 30. North America Modafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Modafinil Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 40. Europe Modafinil Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Modafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 45. France Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Modafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Modafinil Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. India Modafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Modafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Modafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Modafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Modafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Modafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Modafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Modafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Modafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Modafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Modafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 81. Modafinil Tablets Industry Chain Mapping
Figure 82. Regional Modafinil Tablets Manufacturing Base Distribution (%)
Figure 83. Global Modafinil Tablets Production Market Share by Region (2020-2031)
Figure 84. Modafinil Tablets Production Process
Figure 85. Regional Modafinil Tablets Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232